COMA
发表于 2025-3-28 16:44:07
http://reply.papertrans.cn/71/7009/700863/700863_41.png
Gesture
发表于 2025-3-28 20:20:04
Chemical Development of Therapeutic Oligonucleotides. Here we discuss selected chemistries used in antisense oligonucleotide (ASO) applications (e.g., small interfering RNA (siRNA), RNase H activation, translational block, splice-switching, and also as aptamers). Recently approved oligonucleotide-based drugs are also presented briefly.
Pastry
发表于 2025-3-29 00:30:12
http://reply.papertrans.cn/71/7009/700863/700863_43.png
兽群
发表于 2025-3-29 05:20:09
Delivery of Antisense Oligonucleotides Mediated by a Hydrogel System: In Vitro and In Vivo Applicati Here we describe the preparation of antisense oligonucleotide-loaded fibrin hydrogels exploring their applications in the context of the nervous system utilizing an organotypic dorsal root ganglion explant in vitro system and an in vivo model of spinal cord injury.
仲裁者
发表于 2025-3-29 10:02:23
Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficaf ASOs. One of the most advanced clinical uses of ASOs is for the treatment of spinal muscular atrophy (SMA). In this chapter, we describe the techniques used for in vitro screening and analysing in vivo biodistribution of CPP-conjugated ASOs targeting the survival motor neuron 2, ., the dose-dependent modifying gene for SMA.
onlooker
发表于 2025-3-29 13:09:24
Identifying Suitable Target Regions and Analyzing Off-Target Effects of Therapeutic Oligonucleotidesprogramming language R, and the calculations and data processing can be carried out on a desktop computer. Our workflow integrates well-established data resources and RNA structure-prediction tools and can be modified easily and expanded as new resources become available.
钻孔
发表于 2025-3-29 16:39:56
http://reply.papertrans.cn/71/7009/700863/700863_47.png
牲畜栏
发表于 2025-3-29 21:34:51
http://reply.papertrans.cn/71/7009/700863/700863_48.png
伪善
发表于 2025-3-30 00:30:11
http://reply.papertrans.cn/71/7009/700863/700863_49.png
Eeg332
发表于 2025-3-30 06:58:35
pitalkosten, Kapitalstruktur, Steuersätzen, Umsatzveränderungen und -wachstum verdeutlichen, dass auch bei ähnlich großen Unternehmen, die Differenz zwischen Steuer- und Marktwerten stark schwankt. Es zeigt sich, dass das Stuttgarter Verfahren nicht immer zu einer Unterbewertung führt, sondern für s